BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8957074)

  • 1. TATA-less promoters of some Ets-family genes are efficiently repressed by wild-type p53.
    Iotsova V; Crépieux P; Montpellier C; Laudet V; Stehelin D
    Oncogene; 1996 Dec; 13(11):2331-7. PubMed ID: 8957074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ETS1 and ETS2 in p53 regulation: spatial separation of ETS binding sites (EBS) modulate protein: DNA interaction.
    Venanzoni MC; Robinson LR; Hodge DR; Kola I; Seth A
    Oncogene; 1996 Mar; 12(6):1199-1204. PubMed ID: 8649821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative regulation of bcl-2 expression by p53 in hematopoietic cells.
    Wu Y; Mehew JW; Heckman CA; Arcinas M; Boxer LM
    Oncogene; 2001 Jan; 20(2):240-51. PubMed ID: 11313951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo complex formation of PU.1 with HDAC1 associated with PU.1-mediated transcriptional repression.
    Kihara-Negishi F; Yamamoto H; Suzuki M; Yamada T; Sakurai T; Tamura T; Oikawa T
    Oncogene; 2001 Sep; 20(42):6039-47. PubMed ID: 11593411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The transcription of the intercellular adhesion molecule-1 is regulated by Ets transcription factors.
    de Launoit Y; Audette M; Pelczar H; Plaza S; Baert JL
    Oncogene; 1998 Apr; 16(16):2065-73. PubMed ID: 9572487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of gene expression by transcription factors Ets-1 and Ets-2.
    Tymms MJ; Kola I
    Mol Reprod Dev; 1994 Oct; 39(2):208-14. PubMed ID: 7826624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-2 and long-term T cell activation induce physical and functional interaction between STAT5 and ETS transcription factors in human T cells.
    Rameil P; Lécine P; Ghysdael J; Gouilleux F; Kahn-Perlès B; Imbert J
    Oncogene; 2000 Apr; 19(17):2086-97. PubMed ID: 10815800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the human leukemia inhibitory factor gene by ETS transcription factors.
    Bamberger AM; Jenatschke S; Schulte HM; Ellebrecht I; Beil FU; Bamberger CM
    Neuroimmunomodulation; 2004; 11(1):10-9. PubMed ID: 14557674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ets-2 interacts with co-repressor BS69 to repress target gene expression.
    Wei G; Schaffner AE; Baker KM; Mansky KC; Ostrowski MC
    Anticancer Res; 2003; 23(3A):2173-8. PubMed ID: 12894593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of ETS family members is important for the function of the c-sis/platelet-derived growth factor-B TATA neighboring sequence in 12-O-tetradecanoylphorbol-13-acetate-treated K562 cells.
    Kujoth GC; Robinson DF; Fahl WE
    Cell Growth Differ; 1998 Jul; 9(7):523-34. PubMed ID: 9690620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and viral trans-acting factors modulate N-myc2 promoter activity in woodchuck liver tumors.
    Flajolet M; Gegonne A; Ghysdael J; Tiollais P; Buendia MA; Fourel G
    Oncogene; 1997 Aug; 15(9):1103-10. PubMed ID: 9285565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53-dependent repression of the human MCL-1 gene encoding an anti-apoptotic member of the BCL-2 family: the role of Sp1 and of basic transcription factor binding sites in the MCL-1 promoter.
    Pietrzak M; Puzianowska-Kuznicka M
    Biol Chem; 2008 Apr; 389(4):383-93. PubMed ID: 18208354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erg, an Ets-family member, differentially regulates human collagenase1 (MMP1) and stromelysin1 (MMP3) gene expression by physically interacting with the Fos/Jun complex.
    Butticè G; Duterque-Coquillaud M; Basuyaux JP; Carrère S; Kurkinen M; Stéhelin D
    Oncogene; 1996 Dec; 13(11):2297-306. PubMed ID: 8957070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FLI1 and EWS-FLI1 function as ternary complex factors and ELK1 and SAP1a function as ternary and quaternary complex factors on the Egr1 promoter serum response elements.
    Watson DK; Robinson L; Hodge DR; Kola I; Papas TS; Seth A
    Oncogene; 1997 Jan; 14(2):213-21. PubMed ID: 9010223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53.
    Mack DH; Vartikar J; Pipas JM; Laimins LA
    Nature; 1993 May; 363(6426):281-3. PubMed ID: 8387645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells.
    Phan RT; Dalla-Favera R
    Nature; 2004 Dec; 432(7017):635-9. PubMed ID: 15577913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene for porcine pregnancy-associated glycoprotein 2 (poPAG2): its structural organization and analysis of its promoter.
    Szafranska B; Miura R; Ghosh D; Ezashi T; Xie S; Roberts RM; Green JA
    Mol Reprod Dev; 2001 Oct; 60(2):137-46. PubMed ID: 11553911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic activation of the TATA-less mouse thymidylate synthase promoter by the Ets transcription factor GABP and Sp1.
    Rudge TL; Johnson LF
    Exp Cell Res; 2002 Mar; 274(1):45-55. PubMed ID: 11855856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of Ets, rel and Sp1-like proteins in lipopolysaccharide-mediated activation of the HIV-1 LTR in macrophages.
    Sweet MJ; Stacey KJ; Ross IL; Ostrowski MC; Hume DA
    J Inflamm; 1998; 48(2):67-83. PubMed ID: 9656143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The regulation of COUP-TFII gene expression by Ets-1 is enhanced by the steroid receptor co-activators.
    Petit FG; Salas R; Tsai MJ; Tsai SY
    Mech Ageing Dev; 2004; 125(10-11):719-32. PubMed ID: 15541767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.